The worldwide diabetes epidemic

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 2, 2012, Pages 93-96

  Lam, David W ^a   LeRoith, Derek ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

diabetes; epidemic; global

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ANTHROPOMETRY; ASIAN; BODY MASS; CLINICAL PRACTICE; DIABETES MELLITUS; DISEASE COURSE; ECONOMIC ASPECT; EPIDEMIC; FOLLOW UP; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GLUCOSE TOLERANCE; HEALTH CARE POLICY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; PANCREAS ISLET BETA CELL; PHYSICAL ACTIVITY; PREVALENCE; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL ASPECT; URBANIZATION;

DEVELOPING COUNTRIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EPIDEMICS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE STYLE; MALE; OBESITY; RISK FACTORS; SOCIOECONOMIC FACTORS; URBANIZATION; WORLD HEALTH;

EID: 84858288248     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e328350583a     Document Type: Review

References (33)

1. Sicree R, Shaw JE, Zimmet PZ. The global burden of diabetes. In: International Diabetes Federation. IDF Diabetes Atlas, 2nd ed. Brussels, Belgium: International Diabetes Federation, 2003. p. 15-71.
2. International Diabetes Federation. IDF Diabetes Atlas, 5th edn. Brussels, Belgium: International Diabetes Federation, 2011. http://www.idf.org/ diabetesatlas
3. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377:557-567.
4. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301:2129-2140.
5. Gu D, Reynolds K, Duan X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003; 46:1190-1198. (Pubitemid 37214976)
6. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010; 362:1090-1101.
7. Drewnowski A, Popkin BM. The nutrition transition: new trends in the global diet. Nutr Rev 1997; 55:31-43. (Pubitemid 27220092)
8. Popkin BM. The nutrition transition and obesity in the developing world. J Nutr 2001; 131:871S-873S. (Pubitemid 32201175)
9. Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002; 287:2414-2423. (Pubitemid 34495441)
10. WHO Expert Consultation et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363:157-63.
11. He J, Klag MJ, Whelton PK, et al. Body mass and blood pressure in a lean population in southwestern China. Am J Epidemiol 1994; 139:380-389. (Pubitemid 24081337)
12. Park YW, Allison DB, Heymsfield SB, Gallagher D. Larger amounts of visceral adipose tissue in Asian Americans. Obes Res 2001; 9:381-387. (Pubitemid 33603863)
13. Indulekha K, Anjana RM, Surendar J, Mohan V. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem 2011; 44:281-287.
14. Ko GT, Chan JC, Cockram CS, Woo J. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 1999; 23:1136-1142.
15. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445:881-885.
16. Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008; 40:1092-1097.
17. Wu Y, Li H, Loos RJ, et al. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes 2008; 57:2834-2842; PMCID: 2551696.
18. Chang C-C, Chang C-T, et al. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genetics. 2010; 6:1-9. This study identified novel genetic susceptibility loci previously not demonstrated in other ethnic populations, highlighting the ethnic genetic variability in diabetes.
19. Janipalli CS, Kumar MV, Vinay DG, et al. Analysis of 32 common susceptibility genetic variants and their combined effect in predicting risk of Type 2 diabetes and related traits in Indians. Diabet Med, in press; doi:10.1111/j.146405491.2011.03438.x.
20. Kooner JS, Saleheen D, Sim X, et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet 2011; 43:984-989.
21. Yamauchi T, Hara K, Maeda S, et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet 2010; 42:864-868. This study specifically compares the UBE2E2 susceptibility loci in Japanese and European populations, finding no significant association in European populations but a signficant association in Japanese populations.
22. Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006; 355:241-250; PMCID: 1762036.
23. Meigs JB, Shrader P, Sullivan LM, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008; 359:2208-2219; PMCID: 2746946.
24. Lyssenko V, Jonsson A, Almgren P, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008; 359:2220-2232.
25. Talmud PJ, Hingorani AD, Cooper JA, et al. Utility of genetic and nongenetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 2010; 340:b4838; PMCID: 2806945. Highlights the current limited clinical utility in the use of genetic risk factors for identifying those at risk for type 2 diabetes whether used alone or in conjunction with traditional models.
26. Lango H, Palmer CN, Morris AD, et al. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 2008; 57:3129-3135; PMCID: 2570411.
27. de Miguel-Yanes JM, Shrader P, Pencina MJ, et al. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care 2011; 34:121-125; PMCID: 3005447.
28. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403; PMCID: 1370926.
29. Lindström J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006; 368:1673-1679. (Pubitemid 46048554)
30. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008; 371:1783-1789. (Pubitemid 351697954)
31. Ramachandran A, Snehalatha C, Mary S, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006; 49:289-297. (Pubitemid 43185397)
32. Saito T, Watanabe M, Nishida J, et al. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch Intern Med 2011; 171:1352-1360.
33. Molsted S, Tribler J, Poulsen PB, Snorgaard O. The effects and costs of a group-based education programme for self-management of patients with Type 2 diabetes. A community-based study. Health Educ Res 2011. [Epub ahead of print]. doi: 10.1093/her/cyr053. Provided demonstration that less individualized programmes for lifestyle interventions can be effective in treating diabetes and also are relatively cost effective.